This activity is expired and is no longer available for CME credit.


Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion: Case Review

Author(s)/Faculty: Pravin U. Dugel, MD
Release Date: 3/4/2015Expiration Date: 2/1/2017
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
With the approval of a pharmacologic option to resolve vitreomacular adhesion, clinicians are tasked to determine how to best incorporate it into their practices. Clinical trials have shown that ocriplasmin is effective, but also that this efficacy is most pronounced in well-selected patients. In this activity, leading clinicians will discuss optimal OCT and clinical selection criteria to ensure that the agent is reserved for patients who are most likely to benefit. As ocriplasmin is used by more clinicians, more is learned about its safety profile, and clinicians will also discuss the adverse events that have been reported in clinical trials as well as in clinical practice.